emerging glp-1 gip weight loss treatments 2025 Harnessing Receptor Agonists for Obesity Treatment: Prospects and Obstacles on the Horizon GLP-1 Shortage = Over -

( )

Individual Genetic Factors in Cortisol Response and GLP-1 Effectiveness Not all individuals respond identically to semaglutide, and genetic variation in stress-hormone pathways may partly explain these differences

VEGFR2 speelt vermoedelijk een belangrijke rol bij de groei, vermenigvuldiging en levensduur van endotheelcellen

Patients with autoimmune diseases often require treatment for these metabolic conditions, raising important questions about semaglutide safety in this population

Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism

Direct body composition data for retatrutide has not been published, but additional results from the Phase 3 trial are expected later this year